Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents

被引：8
|
作者：
Rizzo, Renata [1 ]
Martino, Davide [2 ,3 ]
机构：
[1] Univ Catania, Neuropsichiatria Infantile, Dipartimento Sci Med & Pediat, I-95123 Catania, Italy
[2] Kings Coll Hosp NHS Fdn Trust, Dept Neurol, London, England
[3] Queen Elizabeth Hosp, Lewisham & Greenwich NHS Trust, London, England
来源：
EXPERT REVIEW OF NEUROTHERAPEUTICS | 2015年 / 15卷 / 04期
关键词：
alpha(2)-adrenoreceptor agonist; attention deficit hyperactivity disorder; guanfacine extended-release; guanfacine immediate-release; treatment; EXTENDED-RELEASE; DEFICIT/HYPERACTIVITY DISORDER; DOUBLE-BLIND; OPEN-LABEL; LONG-TERM; PHASE-I; ADHD; PHARMACOKINETICS; PSYCHOSTIMULANTS; NEUROBIOLOGY;
D O I：
10.1586/14737175.2015.1028370
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Guanfacine is an (2A)-adrenoreceptor agonist currently indicated for the treatment of attention deficit hyperactivity disorder (ADHD). This article reviews the chemistry, pharmacodynamics and pharmacokinetics of guanfacine, as well as the clinical trial literature on guanfacine for the treatment of ADHD in children and adolescents, mainly focusing on the use of guanfacine extended-release (GXR). Six already published prospective randomized controlled trials (RCTs) and one unpublished RCT study were identified for GXR in the treatment of ADHD. All RCTs trials showed superiority over placebo on the primary outcome measure. Guanfacine, especially XR, seems to be an effective and safe treatment option for ADHD in children and adolescents.
引用
收藏
页码：347 / 354
页数：8
相关论文
共 50 条
  • [21] Guanfacine for the Treatment of Attention-Deficit Hyperactivity Disorder: An Updated Systematic Review and Meta-Analysis
    Yu, Sijie
    Shen, Sihao
    Tao, Ming
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2023, 33 (02) : 40 - 50
  • [22] Efficacy of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder
    Newcorn, Jeffrey H.
    Huss, Michael
    Connor, Daniel F.
    Hervas, Amaia
    Werner-Kiechle, Tamara
    Robertson, Brigitte
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2020, 41 (07): : 565 - 570
  • [23] Background, clinical features and treatment of attention deficit hyperactivity disorder in children
    Warikoo, Nisha
    Faraone, Stephen V.
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (14) : 1885 - 1906
  • [24] Response/Remission With Guanfacine Extended-Release and Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
    Cutler, Andrew J.
    Brams, Matthew
    Bukstein, Oscar
    Mattingly, Gregory
    McBurnett, Keith
    White, Carla
    Rubin, Jonathan
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2014, 53 (10): : 1092 - 1101
  • [25] Spotlight on Atomoxetine in Attention-Deficit Hyperactivity Disorder in Children and Adolescents
    Garnock-Jones, Karly P.
    Keating, Gillian M.
    CNS DRUGS, 2010, 24 (01) : 85 - 88
  • [26] Nonstimulant Medications for Treatment of Attention-Deficit/ Hyperactivity Disorder in Children and Adolescents
    Vilus, Jean Taj
    Engelhard, Caitlin
    PEDIATRIC ANNALS, 2025, 54 (01): : e27 - e33
  • [27] An update on the pharmacological treatment of attention deficit hyperactivity disorder: lisdexamphetamine and extended-release guanfacine
    Martin Fernandez-Mayoralas, Daniel
    Laura Fernandez-Perrone, Ana
    Munoz-Jareno, Nuria
    Fernandez-Jaen, Alberto
    REVISTA DE NEUROLOGIA, 2017, 64 : S1 - S8
  • [28] Extended-release medications for children and adolescents with attention-deficit hyperactivity disorder
    Feldman, M.
    Belanger, S.
    PAEDIATRICS & CHILD HEALTH, 2009, 14 (09) : 593 - 596
  • [29] Factors Associated with Atomoxetine Efficacy for Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
    Scott, Nakia Gray
    Ripperger-Suhler, Jane
    Rajab, M. Hasan
    Kjar, Dean
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2010, 20 (03) : 197 - 203
  • [30] Epilepsy and attention-deficit/hyperactivity disorder in children and adolescents: An overview of etiology, prevalence, and treatment
    Uliel-Sibony, Shimrit
    Chernuha, Veronika
    Latzer, Itay Tokatly
    Leitner, Yael
    FRONTIERS IN HUMAN NEUROSCIENCE, 2023, 17
12345